Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma

Chemo/radiotherapies are the most common adjuvant modality treated for patients with glioblastoma (GBM) following surgery. However, the overall therapeutic benefits are still uncertain, as the mortality remains high. Elevated expression of YKL-40 in GBM was correlated with increases in mural cell-as...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Shao, Rong, Francescone, Ralph, Ngernyuang, Nipaporn, Bentley, Brooke, Taylor, Sherry L., Moral, Luis, Yan, Wei
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2014
Ämnen:
Original Manuscript
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908752/
https://ncbi.nlm.nih.gov/pubmed/24282289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgt380
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk